Pulmonary Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Pulmonary Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs) [Phase 3]
Phase 3 trial evaluating tarlatamab vs standard-of-care chemotherapy in pre-treated advanced pulmonary or gastroenteropancreatic poorly diff…
-
CLINICAL_TRIALS trial_result · 2025-04-01Clinical Trial Update: Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs) [Phase 2]
Phase 2 trial evaluating nivolumab with or without ipilimumab in patients with advanced, refractory pulmonary or gastroenteropancreatic poor…